0001209191-22-047431.txt : 20220824 0001209191-22-047431.hdr.sgml : 20220824 20220824210120 ACCESSION NUMBER: 0001209191-22-047431 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220731 FILED AS OF DATE: 20220824 DATE AS OF CHANGE: 20220824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castagna Michael CENTRAL INDEX KEY: 0001674282 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50865 FILM NUMBER: 221192774 MAIL ADDRESS: STREET 1: 25134 RYE CANYON LOOP STREET 2: SUITE 300 CITY: VALENCIA STATE: CA ZIP: 91355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANNKIND CORP CENTRAL INDEX KEY: 0000899460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133607736 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 BUSINESS PHONE: 818-661-5000 MAIL ADDRESS: STREET 1: 1 CASPER STREET CITY: DANBURY STATE: CT ZIP: 06810 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2022-07-31 2022-08-01 0 0000899460 MANNKIND CORP MNKD 0001674282 Castagna Michael 1 CASPER STREET DANBURY CT 06810 1 1 0 0 Chief Executive Officer Common Stock, $0.01 Par Value 2022-07-31 4 A 0 3147 2.93 A 2084486 D This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022. /s/ Michael Castagna 2022-08-24